Cargando…
Pharmacoeconomic evaluations in the treatment of actinic keratoses
Actinic keratoses (AKs) develop as a consequence of chronic ultraviolet (UV) exposure and exist on a continuum with squamous cell carcinoma (SCC). As one of the most common conditions treated by dermatologists, AK places a significant burden on patients and the healthcare system. A range of treatmen...
Autores principales: | Tolley, Keith, Argenziano, Giuseppe, Calzavara-Pinton, Pier Giacomo, Larsson, Thomas, Ryttig, Lasse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806796/ https://www.ncbi.nlm.nih.gov/pubmed/28580871 http://dx.doi.org/10.1177/0394632017697719 |
Ejemplares similares
-
Topical Pharmacotherapy for Actinic Keratoses in Older Adults
por: Calzavara-Pinton, Piergiacomo, et al.
Publicado: (2022) -
Optimal treatment of actinic keratoses
por: Uhlenhake, Elizabeth E
Publicado: (2013) -
Diclofenac gel in the treatment of actinic keratoses
por: Nelson, Christopher G
Publicado: (2011) -
Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014) -
Sequential Treatment of Multiple Actinic Keratoses with Solaraze and Actikerall
por: Dirschka, Thomas, et al.
Publicado: (2014)